VivoSeq
Other

Uric Acid

0

Pipeline Programs

1

Active Trials

2

Companies Involved

Uric Acid is an early-stage landscape with 0 programs across 2 companies. The most active players are Selecta Biosciences, Inc., AstraZeneca.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

92/100

Attrition Rate

6/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

17

clinical trials

Completed12 · 71%
Unknown status3 · 18%
Recruiting1 · 6%
Withdrawn1 · 6%

Trial Activity

17 trials

Lowering Uric Acid in Live Kidney Donors
Completed·OOslo University Hospital·Phase 2·NCT03353298·71 enrolled
Phentermine/Topiramate for Uric Acid Stones
Completed·UUniversity of Florida·Phase 3·NCT04621929·19 enrolled
Uric Acid Study in Healthy Male Volunteers
Completed·AstraZeneca logoAstraZeneca·Phase 1·NCT00738842·24 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)